Yoshikazu Kinoshita (Department of Digestive and Hepatic Medicine, Faculty of Medicine, Shimane
University) with regard to the extramural review. MI-503 References 1. Goldgerg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004, 22: 23–30.CrossRef 2. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004, 22: 229–37.CrossRefPubMed CDK inhibitor 3. Japanese Society for Cancer of the Colon and Rectum: Guidelines for Management of Colon Cancer (for Physicians, Version 2005). Tokyo: Kanehara & Co., Ltd; 2005. 4. Therasse P, Arbuck
SG, Eisenhauer E, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000, 92: 205–216.CrossRefPubMed 5. The advanced colorectal meta-analysis project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992, 10: 893–903. 6. Davis HL: Chemotherapy of large bowel cancer. Cancer 1982, 50: 2638–2646.CrossRefPubMed 7. O’Connell MJ: A phase III trial of 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer. Cancer 1989, 63: 1026–1030.CrossRefPubMed 8. Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK, Hart LL, Gupta S, Garay CA, Burger BG, Le Bail N, Haller DG: Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim Results of a phase III trial. J Clin
Oncol 2003, 21: 2059–2069.CrossRefPubMed 9. de Gramont A, Figer A, Seymour M, Homerin M, Cassidy HJ, Boni C, Cortes-Funes H, Cervantes click here A, Freyer G, Papamichael D, Le Bail N, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000, 18: 2938–2947.PubMed 10. Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, OICR-9429 manufacturer Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Le Rol A, Walter S, Adam R, Misset JL, Lévi F: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000, 18: 136–147.PubMed 11.